Limiting deleterious cross-talk between failing organs

Critical Care Medicine

Volumn 32, Issue 11, 2004, Pages 2358-2359

  Molls, Roshni R ^a   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Intestine; Ischemia; Lung; Multiple organ dysfunction syndrome

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE; FIBRINOGEN; FREE RADICAL; HYDROGEN PEROXIDE; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; NITRIC OXIDE; PADGEM PROTEIN; PHOSPHOLIPASE; REACTIVE OXYGEN METABOLITE; SELECTIN; SERUM AMYLOID A; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; BODY REGIONS; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; EDITORIAL; ENDOTHELIUM CELL; EPITHELIUM CELL; HYPOXEMIA; INTESTINE ISCHEMIA; ISCHEMIA; KUPFFER CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LIMULUS LYSATE TEST; MICROGLIA; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; SWINE; T LYMPHOCYTE;

ANIMALS; ANOXEMIA; CRITICAL CARE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTESTINES; ISCHEMIA; MULTIPLE ORGAN FAILURE; NEUTROPHILS; REPERFUSION; REPERFUSION INJURY; SWINE;

EID: 8544265349     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000145957.97995.55     Document Type: Editorial

References (13)

1. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001; 29:S99-S106
2. Garden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190:255-266
3. Johnson D, Mayers I: Multiple organ dysfunction syndrome: A narrative review. Can J Anaesth 2001; 48:502-509
4. Rabb H, Daniels F, O'Donnell M, et al: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279:F525-F531
5. Rankin JA: Biological mediators of acute inflammation. AACN Clin Issues 2004; 15:3-17
6. de Perrot M, Liu M, Waddell TK, et al: Ischemia-reperfusion-induced lung injury. Am J Resptr Crit Care Med 2003; 167:490-511
7. Serafin A, Fernandez-Zabakgui L, Prats N, et al: Ischemic preconditioning: Tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol 2004; 19:281-289
8. Emsley HC, Tyrrell PJ: Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002; 22:1399-1419
9. Mulvihill NT, Foley JB: Inflammation in acute coronary syndromes. Heart 2002; 87:201-204
10. Kramer AA, Postler G, Salhab KF, et al: Renal ischemia/reperfusion leads to macrophagemediated increase in pulmonary vascular permeability. Kidney Int 1999; 55:2362-2367
11. Kong SE, Blennerhassett LR, Heel KA, et al: 11schaemia-reperfusion injury to the intestine. Aust N Z J Surg 1998; 68:554-561
12. Douzinas EE, Kollias S, Tiniakos D, et al: Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory response. Crit Care Med 2004; 32:2279-2283
13. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308